Xencor | Ativos

Assets Alterar Data
AbbVie USD 148.87B 12.65B 2024-03
Alnylam Pharmaceuticals USD 3.82B 5.49M 2024-03
Amgen USD 92.98B 4.17B 2024-03
Arrowhead Research USD 955.15M 328.86M 2024-03
AstraZeneca USD 102.29B 1.17B 2024-03
Biogen USD 26.57B 277.2M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Cytokinetics USD 808.08M 16.23M 2024-03
GlaxoSmithKline GBP 58.51B 494M 2024-03
J&J USD 171.97B 5.9B 2024-03
MacroGenics USD 248.28M 50.13M 2024-03
Merck USD 105.85B 878M 2024-03
Novartis USD 94.33B 5.61B 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
Xencor USD 884.26M 68.44M 2024-03



Xencor Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.